1. Home
  2. BDTX vs WHF Comparison

BDTX vs WHF Comparison

Compare BDTX & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • WHF
  • Stock Information
  • Founded
  • BDTX 2014
  • WHF 2011
  • Country
  • BDTX United States
  • WHF United States
  • Employees
  • BDTX N/A
  • WHF N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • WHF Finance Companies
  • Sector
  • BDTX Health Care
  • WHF Finance
  • Exchange
  • BDTX Nasdaq
  • WHF Nasdaq
  • Market Cap
  • BDTX 181.4M
  • WHF 162.2M
  • IPO Year
  • BDTX 2020
  • WHF 2012
  • Fundamental
  • Price
  • BDTX $3.94
  • WHF $7.14
  • Analyst Decision
  • BDTX Strong Buy
  • WHF Hold
  • Analyst Count
  • BDTX 5
  • WHF 4
  • Target Price
  • BDTX $10.40
  • WHF $9.17
  • AVG Volume (30 Days)
  • BDTX 1.0M
  • WHF 163.9K
  • Earning Date
  • BDTX 11-05-2025
  • WHF 11-10-2025
  • Dividend Yield
  • BDTX N/A
  • WHF 24.69%
  • EPS Growth
  • BDTX N/A
  • WHF N/A
  • EPS
  • BDTX 0.25
  • WHF 0.15
  • Revenue
  • BDTX $70,000,000.00
  • WHF $81,499,000.00
  • Revenue This Year
  • BDTX N/A
  • WHF N/A
  • Revenue Next Year
  • BDTX N/A
  • WHF N/A
  • P/E Ratio
  • BDTX $15.92
  • WHF $47.24
  • Revenue Growth
  • BDTX N/A
  • WHF N/A
  • 52 Week Low
  • BDTX $1.20
  • WHF $6.53
  • 52 Week High
  • BDTX $4.45
  • WHF $12.18
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 55.43
  • WHF 45.56
  • Support Level
  • BDTX $3.88
  • WHF $6.53
  • Resistance Level
  • BDTX $4.45
  • WHF $7.25
  • Average True Range (ATR)
  • BDTX 0.27
  • WHF 0.26
  • MACD
  • BDTX -0.02
  • WHF 0.09
  • Stochastic Oscillator
  • BDTX 38.32
  • WHF 84.72

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About WHF WhiteHorse Finance Inc.

WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.

Share on Social Networks: